CLX - The Clorox Company

NYSE - NYSE Delayed Price. Currency in USD
148.69
+2.08 (+1.42%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close146.61
Open147.49
Bid0.00 x 800
Ask0.00 x 1300
Day's Range146.88 - 149.33
52 Week Range113.57 - 153.38
Volume604,374
Avg. Volume1,070,590
Market Cap18.986B
Beta (3Y Monthly)0.36
PE Ratio (TTM)23.75
EPS (TTM)6.26
Earnings DateOct 31, 2018
Forward Dividend & Yield3.84 (2.65%)
Ex-Dividend Date2018-10-30
1y Target Est136.36
Trade prices are not sourced from all markets
  • Cramer's No. 1 fear in this market? The rally in shares o...
    CNBC Videosyesterday

    Cramer's No. 1 fear in this market? The rally in shares o...

    Jim Cramer explains why a surge in a stock like Clorox can mean bad news for the broader economy.

  • Cramer's No. 1 fear in this market
    CNBC Videosyesterday

    Cramer's No. 1 fear in this market

    Jim Cramer explains why a surge in a stock like Clorox can mean bad news for the broader economy.

  • Global oil supply hits 100 barrels per day
    Yahoo Finance Video5 days ago

    Global oil supply hits 100 barrels per day

    Yahoo Finance's Seana Smith, Dion Rabouin, Jen Roger and Brian Sozzi discuss what's next for oil with Bubba Trading's Todd Horwitz.

  • Cramer's consumer staples 'power ranking'
    CNBC Videos7 days ago

    Cramer's consumer staples 'power ranking'

    Jim Cramer flags the power players in the consumer staples space, which includes makers of household needs like food, beverages and personal care products.

  • Cramer's 'power ranking' for consumer staples: Constellat...
    CNBC Videos7 days ago

    Cramer's 'power ranking' for consumer staples: Constellat...

    Jim Cramer flags the power players in the consumer staples space, which includes makers of household needs like food, beverages and personal care products.

  • TheStreet.com11 hours ago

    Clorox Is Giving Me Mixed Signals

    has made a strong rally from 2013 (see the Point and Figure chart below) but the weekly bar chart shows a wide trading range market the past three years. In this daily bar chart of CLX, below, we can see that prices display an up and down pattern. The daily On-Balance-Volume (OBV) line shows a rise from May and suggests that CLX will move to new highs.

  • Kimberly-Clark: Analysts’ Recommendations and Target Price
    Market Realist17 hours ago

    Kimberly-Clark: Analysts’ Recommendations and Target Price

    A few Wall Street analysts downgraded Kimberly-Clark (KMB) stock before its third-quarter results. On October 10, Deutsche Bank downgraded Kimberly-Clark stock to “sell” from “hold” and lowered the target price to $99 from $108. On October 8, Goldman Sachs downgraded Kimberly-Clark stock to “neutral” from “buy” and reduced the target price by $1 to $119.

  • CNBCyesterday

    Cramer Remix: Investors should take a bite of this stock

    CNBC's Jim Cramer breaks down why last week’s sell-off is making Yum Brands’ stock an attractive buy into weakness. The "Mad Money" host also hears from cannabis producer MedMen's co-founder and CEO, Adam Bierman. Marketwide stock declines may have investors questioning whether their stock picks are dropping for the right reasons, so on Monday, CNBC's Jim Cramer decided to pinpoint a winner on the decline: Yum Brands YUM .

  • CNBCyesterday

    Cramer's No. 1 fear in this market? The rally in shares of Clorox

    CNBC's Jim Cramer explains why a surge in a stock like Clorox can mean bad news for the broader economy. The "Mad Money" host connects the move to the Fed's rate hike plans. As the stock market tried and failed to regain its bull status on Monday, with the tech sector driving the major averages lower into the close, what really worried CNBC's Jim Cramer were the stocks going up.

  • Kimberly-Clark’s Margins Could Continue to Slide
    Market Realistyesterday

    Kimberly-Clark’s Margins Could Continue to Slide

    Kimberly-Clark’s (KMB) profit margins haven’t impressed investors in the past several quarters. The company continues to struggle on the margins front. Lower pricing, increased commodity and shipping costs, and soft volumes have taken a toll on the company’s profitability.

  • Analysts Expect Kimberly-Clark’s Top Line to Decline
    Market Realist2 days ago

    Analysts Expect Kimberly-Clark’s Top Line to Decline

    Analysts expect Kimberly-Clark (KMB) to report total revenues of $4.5 billion in the third quarter—down 2.1% compared to the same period last year. Analysts expect soft volumes and weak pricing to continue to hurt the company’s organic sales growth rate and overall sales. Negative currency rates pose a threat to the top line in the third quarter.

  • Kimberly-Clark: Weak Q3 Results Could Weigh on the Stock
    Market Realist2 days ago

    Kimberly-Clark: Weak Q3 Results Could Weigh on the Stock

    Kimberly-Clark (KMB) is scheduled to announce to its third-quarter results on October 22. However, analysts’ estimate for the third quarter reflects that the company will likely disappoint investors with its sales and earnings performance.

  • IFF Opens Two New Facilities in China
    Market Realist2 days ago

    IFF Opens Two New Facilities in China

    On October 8, International Flavors and Fragrances (IFF) announced that it opened two new facilities in China. The first facility is a flavor manufacturing plant in the free trade zone of Zhangjiagang, which opened on October 9. The second facility is a natural product research lab located in the Nanjing Life Science Park, which will open on October 15.

  • Procter & Gamble: Analysts’ Recommendations before Q1 2019
    Market Realist5 days ago

    Procter & Gamble: Analysts’ Recommendations before Q1 2019

    Wall Street analysts are maintaining a neutral outlook on Procter & Gamble (PG) stock. Of the 24 analysts tracking PG stock, 17 analysts recommend a “hold” rating, six analysts suggest a “buy,” and one analyst recommends a “sell.” Analysts have a consensus target price of $84.08 per share on PG stock, which indicates an upside of 3.2% based on its closing price of $81.44 on October 10.

  • CL, CHD, and CLX’s Valuations Don’t Look Attractive Yet
    Market Realist5 days ago

    CL, CHD, and CLX’s Valuations Don’t Look Attractive Yet

    As we discussed in Part 1, Colgate-Palmolive (CL), Church & Dwight (CHD), and Clorox (CLX) shares declined considerably in the past few days following Deutsche Bank’s negative stance. Despite the recent decline, the companies’ stocks aren’t attractive on the valuation front.

  • Analyzing the Weakness in KMB, PG, CL, CHD, and CLX
    Market Realist5 days ago

    Analyzing the Weakness in KMB, PG, CL, CHD, and CLX

    Shares of consumer packaged goods manufacturers in the United States have decline considerably in the past few days. Deutsche Bank turned negative on the prospects of the companies operating in the consumer packaged goods sector on October 10.

  • What Analysts Forecast for P&G’s Bottom Line in Q1 2019
    Market Realist5 days ago

    What Analysts Forecast for P&G’s Bottom Line in Q1 2019

    So far, Procter & Gamble (PG) has impressed with its bottom-line performance and has a strong track record of exceeding analysts’ expectations. Procter & Gamble has exceeded analysts’ earnings estimates in the last 13 consecutive quarters, with an average earnings surprise of 4.4%. This performance comes amid a weak sales and margins environment.

  • GlobeNewswire5 days ago

    Market Trends Toward New Normal in Antero Resources, SunPower, The Clorox, CECO Environmental, Fortinet, and Pure Storage — Emerging Consolidated Expectations, Analyst Ratings

    NEW YORK, Oct. 12, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • Why Analysts Expect P&G’s Top Line to Decline in Q1 2019
    Market Realist5 days ago

    Why Analysts Expect P&G’s Top Line to Decline in Q1 2019

    Procter & Gamble (PG) hasn’t impressed with its top-line performance in the past several quarters, and analysts don’t expect this trend to change soon. Analysts expect Procter & Gamble’s top line to remain weak at least in the first half of fiscal 2019, marking a YoY (year-over-year) decline. Analysts expect Procter & Gamble (PG) to report net sales of $16.5 billion in the first quarter of fiscal 2019, which implies a YoY decline of 0.8%.

  • Weak Q1 2019 Results Could Dent Procter & Gamble Stock
    Market Realist5 days ago

    Weak Q1 2019 Results Could Dent Procter & Gamble Stock

    On October 19, Procter & Gamble (PG) plans to announce its earnings for the first quarter of fiscal 2019, which ended on September 30. However, analysts have a dim outlook for the quarter, which could hurt investor sentiment and PG stock.

  • CNBC7 days ago

    Cramer's consumer staples 'power ranking': Constellation, Costco, McCormick, Clorox, Estee Lauder

    CNBC's Jim Cramer flags the power players in the consumer staples space, which includes makers of household needs like food, beverages and personal care products. The "Mad Money" host says Constellation Brands, Costco and others stand out. In the spirit of football season, CNBC's Jim Cramer has taken up a new strategy for finding each stock market sector's power players — stocks that may have been inconsistent in the past, but look better than the competition at the moment.

  • Why Goldman Sachs Downgraded Kimberly-Clark Stock
    Market Realist8 days ago

    Why Goldman Sachs Downgraded Kimberly-Clark Stock

    On October 8, Goldman Sachs downgraded Kimberly-Clark (KMB) stock to “neutral” from “buy” and lowered the target price from $120 to $119 per share. Continued inflation in input cost and weakness in the personal care segment could restrict the growth for Kimberly-Clark. Also, the company’s current valuations don’t seem attractive. Kimberly-Clark stock trades at 17.2x the estimated 2018 EPS of $6.66 and 16.3x the estimated 2019 EPS of $6.99. Both these multiples look expensive based on the projected growth rate of 6.9% and 5.0% in those periods.

  • Burt's Bees to Sponsor and Present Data at Dermveda’s Inaugural Integrative Dermatology Symposium (IDS)
    Business Wire8 days ago

    Burt's Bees to Sponsor and Present Data at Dermveda’s Inaugural Integrative Dermatology Symposium (IDS)

    Burt’s Bees, a leading provider of personal care products committed to providing natural health and beauty solutions, today announced that it will be sponsoring Dermveda’s first annual Integrative Dermatology Symposium .

  • IFF Gained 6.8% in September: Can It Maintain Its Momentum?
    Market Realist8 days ago

    IFF Gained 6.8% in September: Can It Maintain Its Momentum?

    International Flavors and Fragrances (IFF) was the second-ranked performer among chemical companies for September. IFF stock gained ~6.8% in September and outperformed the SPDR S&P 500 ETF Trust (SPY). SPY posted a slim gain of 0.4% for the month.

  • TheStreet.com12 days ago

    Jim Cramer: Focus on the Long Term in This Algo-Driven Bond Squall

    When you look at, say, Clorox, with a five-year net EPS growth of 6% and 3% sales growth, with commodity inflation and logistics crimping last quarter's gross margins by 170 basis points -- from 45.75% to 44% -- you have to say, why should this stock's 2.6% yield sustain it ,given the bond selling onslaught?